Clinical Trial Update: Ramosetron on Late PONV (Postoperative Nausea and Vomiting) [Phase 4]

View source ↗

Summary

Phase 4 trial update on Ramosetron for postoperative nausea and vomiting in female breast cancer patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Postoperative Nausea and Vomiting

Drugs mentioned

• Ramosetron (ramosetron)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Postoperative Nausea and Vomiting, Breast Cancer Female | Phase 4 | Status: COMPLETED